会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • COMPOUNDS AND METHODS FOR THE TREATMENT OF UROGENITAL DISORDERS
    • 化合物和治疗溃疡性疾病的方法
    • WO2002069906A2
    • 2002-09-12
    • PCT/US2002/007026
    • 2002-03-06
    • CELLEGY PHARMACEUTICALS, INC.MAK, Vivien, H., W.GRAYSON, Stephen
    • MAK, Vivien, H., W.GRAYSON, Stephen
    • A61K
    • A61K45/06A61K31/00A61K31/5513A61K31/554A61K31/56A61K38/446A61K38/4886A61K2300/00
    • The present invention provides methods for treating a variety of urogenital disorders, such as, for example, vaginismus, dyspareunia, vulvodynia (including vulvar vestibulitis), interstitial cystitis, nonspecific urethriris (i.e., nonspecific pain and/or burning of the urinary tract) and sexual dysfunctions, such as, for example, female sexual arousal disorders and female sexual orgasmic disorders, using a variety of compounds, including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators, a-adrenergic receptor antagonists, b-adrenergic receptor agonists, phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators, estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists, bisphosphonates and cGMP-dependent protein kinase activators (e.g., cGMP mimetics).
    • 本发明提供了治疗各种泌尿生殖系统疾病的方法,例如阴道炎,性交疼痛,外阴(包括外阴前庭炎),间质性膀胱炎,非特异性尿道炎(即非特异性疼痛和/或尿道灼伤)和 使用各种化合物,包括但不限于NO供体,钙通道阻断剂,胆碱能调节剂,α-肾上腺素能受体拮抗剂,β-肾上腺素能受体拮抗剂,β-肾上腺素能受体拮抗剂, 肾上腺素能受体激动剂,磷酸二酯酶抑制剂,cAMP依赖性蛋白激酶激活剂(例如cAMP模拟物),超氧化物清除剂,钾通道激活剂,雌激素样化合物,睾酮样化合物,苯二氮卓类,肾上腺素能神经抑制剂,止泻药,HMG-CoA还原酶 抑制剂,平滑肌松弛剂,腺苷受体调节剂,腺苷酸环化酶激活剂,内皮素受体拮抗剂 一次性,双膦酸盐和cGMP依赖性蛋白激酶激活剂(例如,cGMP模拟物)。
    • 7. 发明申请
    • COMPOSITIONS AND METHODS FOR THE TREATMENT OF ANORECTAL DISORDERS
    • 用于治疗异位性疾病的组合物和方法
    • WO2003075851A2
    • 2003-09-18
    • PCT/US2003/007106
    • 2003-03-05
    • CELLEGY PHARMACEUTICALS, INC.PARKS, Thomas, P.MAK, Vivien, H., W.LEE, Jung-ChungLEE, CharlesGRAYSON, Stephen
    • PARKS, Thomas, P.MAK, Vivien, H., W.LEE, Jung-ChungLEE, CharlesGRAYSON, Stephen
    • A61K
    • A61K31/00
    • Compositions and methods for the treatment of patients with anorectal disorders including colostomy are provided in which certain compounds including, but not limited to, NO donors, calcium channel blockers, cholinergic modulators (including acetylcholine storage blocking agents and acetylcholine vesicle storage blocking agents), $g(a)-adrenergic receptor antagonists (including $g(a)¿1?-adrenergic antagonists and $g(a)¿2?-adrenergic antagonists), $g(b)-adrenergic receptor agonists (including $g(b)¿2?-adrenergic antagonists and $g(b)¿3?-adrenergic antagonists), phosphodiesterase inhibitors, cAMP-dependent protein kinase activators (e.g., cAMP mimetics), superoxide scavengers, potassium channel activators (including ATP-sensitive potassium channel activators and activators of the Maxi-K channels), estrogen-like compounds, testosterone-like compounds, benzodiazepines, adrenergic nerve inhibitors, antidiarrheal agents, HMG-CoA reductase inhibitors, smooth muscle relaxants, adenosine receptor modulators, adenylyl cyclase activators, endothelin receptor antagonists, bisphosphonates, cGMP-dependent protein kinase activators (e.g., cGMP mimetics), and combinations thereof are used.
    • 提供了用于治疗包括结肠造口术在内的肛门直肠疾病患者的组合物和方法,其中某些化合物包括但不限于NO供体,钙通道阻断剂,胆碱能调节剂(包括乙酰胆碱储存阻断剂和乙酰胆碱泡囊阻滞剂),$ g(a) - 肾上腺素受体拮抗剂(包括$ g(a)1 - 肾上腺素能拮抗剂和$ g(a)2'-肾上腺素能拮抗剂),$ g(b) - 肾上腺素能受体激动剂(包括$ g )2'-肾上腺素能拮抗剂和$ g(b)3'-肾上腺素能拮抗剂),磷酸二酯酶抑制剂,cAMP依赖性蛋白激酶激活剂(例如cAMP模拟物),超氧化物清除剂,钾通道激活剂(包括ATP敏感钾通道 Maxi-K通道的激活剂和激活剂),雌激素样化合物,睾酮样化合物,苯并二氮杂,肾上腺素能神经抑制剂,止泻药,HMG-CoA还原酶抑制剂,平滑肌松弛剂,腺苷 受体调节剂,腺苷酸环化酶激活剂,内皮素受体拮抗剂,双膦酸盐,cGMP依赖性蛋白激酶激活剂(例如,cGMP模拟物)及其组合。